In recent years, the receptor tyrosine kinase HER3 (also known as ErbB3) has emerged from relative obscurity to occupy a...

In a groundbreaking advancement within the realm of neuro-oncology, researchers have unveiled a compelling synthetic lethality approach targeting MTAP homozygous-deficient...

In the relentless quest to better understand and treat cancer, the concept of surrogate end points has surfaced as a...

In the landscape of contemporary oncology, the quest for personalized cancer therapies has accelerated with unprecedented vigor. A groundbreaking study...

In a groundbreaking advance bridging neurobiology and oncology, recent research has unveiled intricate interactions between melanoma progression and the nervous...

In recent years, the intricate relationship between DNA repair mechanisms and cancer development has come into sharper focus, spotlighting a...

In recent years, the landscape of multiple myeloma (MM) diagnosis and treatment has undergone a profound transformation, largely driven by...

The landscape of cancer diagnostics has witnessed transformative advancements, particularly in the realm of human epidermal growth factor receptor 2...

In a groundbreaking advancement poised to reshape the therapeutic landscape of advanced gastric cancer, researchers have unveiled compelling evidence supporting...

In an era where early cancer detection defines the edge of clinical success, a groundbreaking study published in BMC Cancer...